AKT1 and renal cell carcinoma: Since the MEK/ERK and AKT/mTOR pathways regulate the key metabolic process in carcinogenesis, approaches targeting the circCYP24A1/miR-421/CMTM4 pathway may become a promising treatment strategy in RCC.